However, some authors found that six months of immunosuppressive treatment (GCs together with CTX or MMF) may decrease urine IL-23 concentrations in patients with a complete response, supporting the potential role of IL-23 in the pathogenesis of LN [26]. This evidence concerns the gene IL37 and lobular neoplasia.